Lipids and Metabolic

heartwire News

  • Alert FDA Warns of Stroke, Death With Off-Label Use of Wingspan Stent Postmarket data show a significantly increased risk of stroke or death when the Wingspan intracranial stent system is used outside the approved indications.
  • Evolocumab Lowers LDL-C in Diabetic Patients on Maximum Statins In patients with type 2 diabetes and hyperlipidemia or mixed dyslipidemia on a maximally tolerated statin, treatment with evolocumab lowers low-density-lipoprotein cholesterol (LDL-C) and improves levels of other lipids, researchers say.
  • Diabetes Has Lethal Consequences in Asia Pooled analysis that included over 1 million adults showed substantially increased risk for all-cause and cause-specific death among those with diabetes; Asian-specific management programs are needed.
  • FDA's Added-Sugar Labeling Policy to Pay Sweet Dividends The first-of-its-kind study projects striking reductions in cardiovascular disease and type 2 diabetes, coupled with billions in cost savings after implementation of an added-sugar labeling policy.

Perspective